Weber S, Babina M, Feller G, Henz B M
Department of Dermatology, Virchow-Klinikum, Humboldt-Universität zu Berlin, Germany.
Scand J Immunol. 1997 May;45(5):471-81. doi: 10.1046/j.1365-3083.1997.d01-420.x.
Mast cells are bone marrow-derived, ubiquitous connective tissue resident cells. However, their mechanisms of migration, the distribution of immature and mature cells and their interaction with other inflammatory cells are largely unclarified. Possibly, beta 2-integrins play an important role in these processes. In the present investigation, the authors studied the expression and regulation of the beta 2-integrins LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), p150,95 (CD11c/CD18) and of the LFA-1/Mac-1 counter-receptor intercellular adhesion molecule-1 (ICAM-1; CD54) on leukaemic (HMC-1 cell subclone 5C6) and on normal mature human skin mast cells. The HMC-1 cells clearly expressed CD11a, CD18 and CD54, while expression of CD11b and CD11c was low. The apparent molecular weights were 180 kDa (CD11a), 95 kDa (CD18) and 90 kDa (CD54) as determined by Western blot analysis. Phorbol myristate acetate (PMA) induced a time- and dose-dependent up-regulation of CD11a, CD11b, CD11c, CD18 and CD54 that was inhibited by cycloheximide, suggesting a dependence on de novo protein synthesis. Enhanced expression of CD11a, CD11b, CD11c and CD18 could also be confirmed at the gene level as demonstrated by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). Increased expression of LFA-1/ICAM-1 in response to PMA was accompanied by strong enhancement of homotypic cell aggregation, suggesting that newly synthesized LFA-1/ICAM-1 is functionally active. In order to determine a physiologically relevant way of mast cell beta 2-integrin modulation, several cytokines and chemotactic mediators (interleukin-4, IL-4; nerve growth factor beta, NGF beta; C5a; and leukotriene B4, LTB4) were tested for their influence on adhesion molecule cell surface density. Only LTB4 was shown specifically to up-regulate CD11a and CD18, but not CD11b or CD11c. The presence of CD11a, CD11c and CD18 could be confirmed on a low percentage of normal skin mast cells by immunofluorescence, using a double staining technique. In comparison to normal skin, a significantly higher percentage of CD18+ mast cells was found in inflammatory dermatoses such as psoriasis vulgaris, atopic dermatitis and lichen planus. Therefore, mast cell beta 2-integrins possibly play an important role during homing of immature mast cells as well as during the interaction of activated mast cells with other inflammatory cells.
肥大细胞起源于骨髓,是广泛存在于结缔组织中的常驻细胞。然而,它们的迁移机制、未成熟和成熟细胞的分布以及它们与其他炎症细胞的相互作用在很大程度上尚不清楚。β2整合素可能在这些过程中发挥重要作用。在本研究中,作者研究了β2整合素LFA-1(CD11a/CD18)、Mac-1(CD11b/CD18)、p150,95(CD11c/CD18)以及LFA-1/Mac-1的反受体细胞间黏附分子-1(ICAM-1;CD54)在白血病(HMC-1细胞亚克隆5C6)和正常成熟人皮肤肥大细胞上的表达和调控。HMC-1细胞明显表达CD11a、CD18和CD54,而CD11b和CD11c的表达较低。通过蛋白质印迹分析确定,其表观分子量分别为180 kDa(CD11a)、95 kDa(CD18)和90 kDa(CD54)。佛波酯肉豆蔻酸酯乙酸酯(PMA)诱导CD11a、CD11b、CD11c、CD18和CD54呈时间和剂量依赖性上调,这种上调被放线菌酮抑制,提示其依赖于从头合成蛋白质。半定量逆转录-聚合酶链反应(RT-PCR)证明,在基因水平上也可证实CD11a、CD11b、CD11c和CD18的表达增强。PMA刺激后LFA-1/ICAM-1表达增加,同时同型细胞聚集显著增强,提示新合成的LFA-1/ICAM-1具有功能活性。为了确定肥大细胞β2整合素调节的生理相关方式,检测了几种细胞因子和趋化介质(白细胞介素-4,IL-4;神经生长因子β,NGFβ;C5a;白三烯B4,LTB4)对黏附分子细胞表面密度的影响。仅LTB4被证明可特异性上调CD11a和CD18,但对CD11b或CD11c无影响。通过双染色免疫荧光技术,可在低比例的正常皮肤肥大细胞上证实CD11a、CD11c和CD18的存在。与正常皮肤相比,在寻常型银屑病、特应性皮炎和扁平苔藓等炎症性皮肤病中,CD18+肥大细胞的比例显著更高。因此,肥大细胞β2整合素可能在未成熟肥大细胞归巢以及活化肥大细胞与其他炎症细胞相互作用过程中发挥重要作用。